Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07419555 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Belgian Lung Function Study

Study acronym: AIRCAST
StatusRecruiting
PhaseNot specified
SponsorKU Leuven
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Enrollment increased: 4000 → 5000 participants Show 5 more changesShow less
    • Study sites: 4 to 5
    • Eligibility criteria expanded, about 7 words
    • Secondary endpoints: details revised at 3 of 6 entries
    • Collaborators: 3 to 4
    • Study description expanded, about 2 words
  2. Notable Recruitment opened
    • Start date changed from estimate of Mar 1, 2026 to Mar 25, 2026
    • Site details revised at 4 of 4 sites
    v3
  3. Minor Study description expanded, about 4 wordsv2
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
69 trials monitored
See all monitored trials
Currently, it remains unclear how to manage serial lung function measurements in a clinical setting. The investigators aimed to tackle this problem by developing a machine learning (ML) model that can accurately predict population and individual lung function trajectories. These predictions would enable the investigators to identify positive or negative deviations, thereby revealing unexpected disease patterns. A prospective validation is needed that includes data on mortality, hospitalisations, emergency-room visits and patient-reported outcomes. Within this study, the goal is to validate the ML model with the data collected from this observational study.
Trial Details
NCT Number NCT07419555
Lead Sponsor KU Leuven
Collaborators: AZ Delta, University Hospital, Antwerp, Ziekenhuis Oost-Limburg, UZ Gent, Belgium
Conditions
(from sponsor)
Chronic Respiratory Diseases
Enrollment 5,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov